Valeant Pharmaceuticals said Friday that the Food and Drug Administration approved its Luzu cream, which is designed to treat fungal infections. The Canadian drugmaker said Luzu, or luliconazole, is intended to treat athlete's foot, jock itch, and ringworm. It said the cream is indicated for...
It always seems like you just can’t get enough of some things: love, money, time, respect. For drug developers interested in studying disease in phenotypically relevant models, it’s cells of interest from a patient’s sample. Because there’s only so much tissue that you can biopsy from a patient, these researchers, like the rest of us, need to figure out how to work with what they have.
An international team of researchers has “harnessed the power of evolution” to create a new drug for possible use against heart disease, inflammation and other illnesses.
On the occasion of the 6th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing new EU-wide data on antibiotic resistance showing a marked increase of carbapenem-resistant infections. The carbapenems are a major last-line class of antibiotics used to treat healthcare-associated infections.
Bayer HealthCare announced that the European Commission has granted marketing authorization for Xofigo solution for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
Merck announced today an investment in a new pharmaceutical manufacturing facility, to be located in the Nantong Economical Technological Development Area (NETDA), in the Greater Shanghai region (Yangtze River Delta area).
Vanda Pharmaceuticals Inc. announced that the FDA Peripheral and Central Nervous System Drugs Advisory Committee voted to recommend the approval of Vanda's NDA for tasimelteon, proposed tradename Hetlioz, for the treatment of Non-24-Hour Disorder in the totally blind.
A study in mice shows processes that age and damage skin are impeded by dilute bleach solution. If it works similarly in humans, it could provide a new way to treat inflammatory skin damage.
Magee-Womens Hospital of UPMC recently became the first hospital in western Pennsylvania to perform a hysterectomy through a single incision using robotic technology. This nearly scar-free surgical option provides women with a state-of-the-art, minimally invasive approach to gynecological surgery.
Genevac has developed a protocol using its SuperCool 75 condenser that, in conjunction with the Genevac HT-12 High Throughput Evaporator, has been proven to set a new benchmark for enhanced evaporation and lyophilisation results.
Porvair Sciences has introduced the Co-Mix- an accurate, reliable, compact and simple-to-use multi-format mixer, designed to improve laboratory mixing productivity.
Novartis announced interim results from a Phase 1 clinical trial with its proprietary cell culture vaccine for the H7N9 avian influenza virus involving 400 healthy volunteers (18 to 64 years of age).
Described as the most important innovation in the discovery of new antibiotics since Alexander Fleming’s original breakthrough more than 80 years ago, small U.K. drug discovery company Helperby Therapeutics has announced a major breakthrough in the fight against resistance with the discovery of patented "resistance breaker" compounds.
Scientists at A*STAR’s Singapore Immunology Network (SIgN) have discovered the exact mode of action by plerixafor, a drug commonly prescribed to stimulate immune responses in patients suffering from neutropenia. How can a better understanding of the drug’s mechanism can improve its usage? Find out...
A molecule that helps cells stick together is significantly over-produced in two very different diseases—rheumatoid arthritis and a variety of cancers, including breast and brain tumors, concludes a new study. Could a drug candidate also discovered by the researchers treat both of these diseases? Find out...